Evidence map›Paper›PMID 22036094›Full record

ReviewThe Journal of allergy and clinical immunology2011

New insights into the natural history of asthma: primary prevention on the horizon.

Fernando D Martinez

Registry-linked trialAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02148796 (Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02148796 phase2completednot on this mapstarted 2017, after this paper: background citation

Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)

TypeinterventionalSponsorUniversity of ArizonaRan2017 to 2026Enrolled822ConditionsAsthma, WheezingArmsBroncho-Vaxom (BV), Placebo
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Psychosocial factors and behavioral medicine interventions in asthma.Journal of consulting and clinical psychology · 2013
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Early Origins of Asthma. Role of Microbial Dysbiosis and Metabolic Dysfunction.American journal of respiratory and critical care medicine · 2018
    Review
  11. Article
  12. Review
  13. Article
  14. Pathogenetic and prognostic roles of bloodborne fibrocytes in asthma.Journal of Zhejiang University. Science. B · 2015
    Review
  15. Risk factors associated with asthma, atopic dermatitis and rhinoconjunctivitis in a rural Senegalese cohort.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2015
    Article
  16. Article
  17. The human microbiome. Early life determinant of health outcomes.Annals of the American Thoracic Society · 2014
    Article
  18. Is asthma an infectious disease? New evidence.Current allergy and asthma reports · 2013
    Review
  19. Asthma.Lancet (London, England) · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Fernando D MartinezArizona Respiratory Center and BIO5 Institute, University of Arizona, Tucson, Ariz 85712, USA. fernando@arc.arizona.edu
University of Arizona · US

Funding

Natural History of Asthma from Birth to Early Adult LifeR01HL056177 · NHLBI · UNIVERSITY OF ARIZONA · PI GUERRA, STEFANO, MARTINEZ, FERNANDO D · 1996 to 2015
$14.4M
Arizona/Duke Clinical Center for AsthmaNetU10HL098112 · NHLBI · UNIVERSITY OF ARIZONA · PI KRAFT, MONICA, MARTINEZ, FERNANDO D · 2009 to 2015
$4.7M
NHLBI NIH HHS R01 HL056177NHLBI NIH HHS U10 HL098112
6 · The paper itself

Abstract

Recent studies of the natural history of asthma have shifted attention toward viral respiratory tract illness in early life as a major risk factor associated with the development of the most persistent forms of the disease. Although early aeroallergen sensitization is strongly associated with chronic asthma, several trials in which single-aeroallergen exposure in pregnancy and early childhood was successfully accomplished and compared with sham avoidance have failed to show any decrease in asthma incidence. New evidence suggests that complex interactions occur between viral infection and aeroallergen sensitization in genetically susceptible subjects that trigger the immune responses and airway changes that are characteristic of persistent asthma. The finding that exposure to bacterial products among children raised on farms is associated with diminished asthma prevalence during the school years has now been replicated, and experimental studies have suggested that these effects are mediated by the activation of regulatory T cells in the airway. It is thus plausible to hypothesize that primary prevention of asthma could be attained through surrogate therapeutic interventions that activate similar mechanisms in young children at high risk for asthma.

Indexed as

Antigens, BacterialAsthmaHumansPrimary PreventionRespiratory Tract InfectionsVirus DiseasesAntigens, Bacterial

Identifiers

PMID22036094
PMCPMC3963825
OpenAlexW2073929741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.